A FDA panel is backing Auxilium Pharmaceuticals (Nasdaq: AUXL) XIAFLEX drug to treat Dupuytren's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE